3
Shared Docs
2
Same-Page
3 / 3
Mentions
no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
victims who are eager to see Epstein face new charges in South Florida, wrote Byung J. Pak, U.S. Attorney for the Northern District of Georgia, and Jill E. Steinberg and Nathan P. Kitchens, special attorneys for the Southern District of Florida. But they conclude that reopening their cases against Epstein in Sou
no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
victims who are eager to see Epstein face new charges in South Florida, wrote Byung J. Pak, U.S. Attorney for the Northern District of Georgia, and Jill E. Steinberg and Nathan P. Kitchens, special attorneys for the Southern District of Florida. But they conclude that reopening their cases against Epstein in Sou
victims who are eager to see Epstein face new charges in South Florida, wrote Byung J. Pak, U.S. Attorney for the Northern District of Georgia, and Jill E. Steinberg and Nathan P. Kitchens, special attorneys for the Southern District of Florida. But they conclude that reopening their cases against Epstein in Sou
Page: EFTA00018472 →no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
Page: EFTA00018482 →Entities connected to both the U.S. Food and Drug Administration and Jill E. Steinberg

Jeffrey Epstein
PERSON
Department of Justice
ORGANIZATIONJane Doe
PERSON
Donald Trump
PERSON
Bradley Edwards
PERSON
Kenneth Marra
PERSON
Julie K. Brown
PERSON
Paul Cassell
PERSON
Stephen Hawking
PERSON
Alexander Acosta
PERSON
Prince Andrew
PERSON
Virginia Giuffre
PERSON
United States
LOCATIONJack Scarola
PERSON
Bloomberg L.P.
ORGANIZATION
Geoffrey S. Berman
PERSON
Alan Dershowitz
PERSON
South Florida
LOCATION
Eric Trump
PERSON
New York
LOCATION